In an interview with Longevity Technology last week, Chromadex CEO Rob Fried discussed the strategy and challenges of selling Nicotinamide Riboside “NR” (FAQs) (Reviews) throughout the world. The following are key quotes:

Chromadex CEO Rob Fried in Longevity Technology:

“We know that at the root of Nicotinamide Riboside (NR) you’re looking at energy metabolism and cell repair,” he explains.

“For NAD, there is an undisputed relationship between elevated NAD levels and mitochondrial function and virtually every disorder associated with aging.

So, energy metabolism and aging are at the root of whatever story we tell.

The science is very clear on that.”

Limits to How Chromadex Can Market Nicotinamide Riboside (NR)

“When you go one level deeper than cell health into specific indications and disease states, regulatory requirements become more complex.

The regulatory requirements vary country by country; some countries allow you to reference diseases. Most do not.

In the US, one can make structure function claims such as heart health or brain health but cannot specifically reference a brain disease such as Alzheimer’s in the materials.”

Full interview HERE.

RELATED:

  • FAQs on taking NAD boosting vitamin supplement Nicotinamide Riboside (NR) can be found HERE.
  • NR supplementation may have helped sufferers of these diseases & conditions (Consumer Reviews)

FOLLOW us on Twitter @RaisingNAD